CancerEMC: frontline non-invasive cancer screening from circulating protein biomarkers and mutations in cell-free DNA | Zendy

Saifur Rahaman | Zendy; Xiangtao Li | Zendy; Jun Yu | Zendy; KaChun Wong | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

CancerEMC: frontline non-invasive cancer screening from circulating protein biomarkers and mutations in cell-free DNA

Author(s) -

Saifur Rahaman,

Xiangtao Li,

Jun Yu,

KaChun Wong

Publication year - 2021

Publication title -

bioinformatics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.599

H-Index - 390

eISSN - 1367-4811

pISSN - 1367-4803

DOI - 10.1093/bioinformatics/btab044

Subject(s) - oversampling , cell free fetal dna , cancer , computer science , computational biology , medicine , biology , pregnancy , computer network , fetus , bandwidth (computing) , prenatal diagnosis , genetics

The early detection of cancer through accessible blood tests can foster early patient interventions. Although there are developments in cancer detection from cell-free DNA (cfDNA), its accuracy remains speculative. Given its central importance with broad impacts, we aspire to address the challenge.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research